Skip to main content
. Author manuscript; available in PMC: 2023 Sep 15.
Published in final edited form as: Nat Med. 2020 Oct 14;26(12):1919–1928. doi: 10.1038/s41591-020-1112-0

Extended Data Table 3.

Results of the external predictive validity (out-of-sample validation) of the estimated no-pandemic counterfactual weekly deaths from the ensemble of Bayesian models. Each number represents the total error over the validation period, averaged across countries

Validation year Age group (years) Projection error (relative projection error) Absolute projection error (relative absolute projection error) Percent covered by 95% credible interval
Men Women Men Women Men Women
2017 0-64 134 (2%) 28 (1%) 265 (7%) 177(9%) 96% 98%
65+ 878 (5%) 1201 (6%) 1036 (7%) 1343 (7%) 93% 91%
2018 0-64 -92 (-3%) -49 (-3%) 278 (8%) 186(9%) 95% 97%
65+ -223 (-2%) -370 (-2%) 1058(7%) 1420 (8%) 88% 87%
2019 0-64 112(2%) 50 (2%) 261 (8%) 164(9%) 96% 96%
65+ 430 (2%) 558 (2%) 696 (4%) 898 (5%) 98% 100%
All three years 0-64 51 (0%) 10(0%) 268 (8%) 176(9%) 95% 97%
65+ 361 (2%) 463 (2%) 930 (6%) 1220 (7%) 93% 93%
*

Australia, France and Italy were not used for validation analysis because they had shorter time series. Hence leaving out the last three years of data would leave a time series that was too short for estimating model parameters.